Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objective</h3><p>Açai is a rich source of anthocyanins and has been used as dietary supplement and active pharmaceutical ingredient. Growing evidence indicates that host-microbial interactions played a vital role in the host metabolism. This study aimed to investigate the anthocyanin-rich extract of açai (<em>Euterpe oleracea Mart.</em>) fruit (AEA) regarding its anti-obesity activity and gut microbiota-modulating effect.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Research Methods & Procedures</h3><p>Thirty-six male SPF C57BL/6J mice were randomly divided into three groups and fed with low-fat diet (LFD), high-fat diet (HFD) or high-fat diet supplemented with AEA for 14 weeks. The anti-obesity effect of AEA was evaluated, and the microbial changes were analyzed by 16S rRNA sequencing. Spearman correlation analysis was used to determine the correlations between gut microbiota and obesity-related indicators.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Our results showed that AEA treatment alleviated HFD-induced obesity, hepatic steatosis, and insulin resistance. Moreover, AEA supplement changed the structure of the gut microbiota, and significantly enriched <em>Akkermansia muciniphila</em>, which was negatively correlated with the physical biomarkers (e.g. serum glucose, insulin and triglycerides) and genes involved in lipid metabolism.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>AEA alleviated HFD-induced obesity, insulin resistance and hepatic steatosis. The microbial changes may be one of the potential mechanisms for AEA in improving obesity and obesity-related disorders.</p>

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore **the effects of anthocyanin - rich acai berry extract (AEA) on obesity, hepatic steatosis and insulin resistance caused by high - fat diet and its potential mechanism through regulating the structure of gut microbiota**. Specifically, the researchers hope to verify the following points through experiments: 1. **Anti - obesity effect**: Evaluate whether AEA can reduce the weight gain caused by high - fat diet. 2. **Improve liver health**: Examine whether AEA can reduce the fat accumulation in the liver, thereby alleviating hepatic steatosis. 3. **Regulate insulin sensitivity**: Research whether AEA can improve the insulin resistance caused by high - fat diet. 4. **Regulate gut microbiota**: Explore whether AEA can change the structure of gut microbiota, especially whether it can increase the proportion of beneficial bacteria such as *Akkermansia muciniphila*, and the relationship between these changes and obesity - related indicators. ### Research methods - **Animal model**: Male SPF C57BL/6J mice were used and randomly divided into three groups, which were fed with low - fat diet (LFD), high - fat diet (HFD) and high - fat diet supplemented with AEA (HFD+AEA) respectively. - **Experimental period**: 14 weeks. - **Detection indicators**: Including body weight, food intake, serum lipid profile, liver histological analysis, oral glucose tolerance test (OGTT), insulin tolerance test (ITT), liver gene expression analysis and gut microbiota composition analysis. ### Main findings - **Body weight and blood lipids**: AEA treatment significantly reduced the weight gain caused by HFD and decreased the levels of triglyceride (TG), total cholesterol (TC), non - esterified fatty acid (NEFA) and low - density lipoprotein cholesterol (LDL - C) in serum. - **Liver health**: AEA reduced the fat accumulation in the liver, alleviated hepatocyte swelling and steatosis, and at the same time decreased the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in serum which reflect liver function. - **Insulin sensitivity**: AEA improved the glucose intolerance and insulin resistance caused by HFD, which was manifested as a decrease in fasting blood glucose and insulin levels and an increase in the insulin sensitivity index (HOMA - IS). - **Gut microbiota**: AEA changed the structure of gut microbiota and increased the proportion of beneficial bacteria *Akkermansia muciniphila*, which was negatively correlated with body weight, blood glucose, insulin and blood lipid levels. ### Conclusion The research results show that **the anthocyanin - rich acai berry extract (AEA) can effectively alleviate obesity, hepatic steatosis and insulin resistance caused by high - fat diet, and its mechanism may be partly attributed to the regulatory effect on gut microbiota**. This finding provides a scientific basis for using acai berry anthocyanins as a natural supplement to prevent obesity and related metabolic diseases.

Dietary anthocyanin-rich extract of açai protects from diet-induced obesity, liver steatosis, and insulin resistance with modulation of gut microbiota in mice

Pomegranate Fruit Pulp Polyphenols Reduce Diet-Induced Obesity with Modulation of Gut Microbiota in Mice.

Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice.

Euterpe oleracea Mart.-Derived Polyphenols Protect Mice from Diet-Induced Obesity and Fatty Liver by Regulating Hepatic Lipogenesis and Cholesterol Excretion

Anti-Obesity Effect of Auricularia Delicate Involves Intestinal-Microbiota-Mediated Oxidative Stress Regulation in High-Fat-Diet-Fed Mice

Anthocyanins from Lycium ruthenicum Murray Prevent High-Fat Diet-Induced Obesity in Female Mice via Gut Microbiota-Related Bile Acids Metabolism

Auricularia auricula polysaccharides attenuate obesity in mice through gut commensal Papillibacter cinnamivorans

Pomegranate peel anthocyanins prevent diet-induced obesity and insulin resistance in association with modulation of the gut microbiota in mice

Amaranth Supplementation Improves Hepatic Lipid Dysmetabolism and Modulates Gut Microbiota in Mice Fed a High-Fat Diet

Preventive Effects of Anthocyanins from Lyciumruthenicum Murray in High-Fat Diet-Induced Obese Mice Are Related to the Regulation of Intestinal Microbiota and Inhibition of Pancreatic Lipase Activity

Anthocyanins from Lycium ruthenicum Murray attenuates high‐fat diet‐induced hypercholesterolemia in ApoE −/− mice are related to the modulation of gut microbiota and the ratio of conjugated to unconjugated bile acids in fecal bile acid profile

Black Current Anthocyanins Improve Lipid Metabolism and Modulate Gut Microbiota in High-Fat Diet-Induced Obese Mice.

Extract of Acalypha australis L. inhibits lipid accumulation and ameliorates HFD-induced obesity in mice through regulating adipose differentiation by decreasing PPARγ and CEBP/α expression

Anti-obesity Effects of Α-Amylase Inhibitor Enriched-Extract from White Common Beans (phaseolus Vulgaris L.) Associated with the Modulation of Gut Microbiota Composition in High-Fat Diet-Induced Obese Rats

Averrhoa carambola L. fruit polyphenols ameliorate hyperlipidemia, hepatic steatosis, and hyperglycemia by modulating lipid and glucose metabolism in mice with obesity

Polysaccharide from Agrocybe cylindracea prevents diet-induced obesity through inhibiting inflammation mediated by gut microbiota and associated metabolites

Heat‐Treated Adzuki Bean Protein Hydrolysates Reduce Obesity in Mice Fed a High‐Fat Diet Via Remodeling Gut Microbiota and Improving Metabolic Function

Xanthophyllomyces dendrorhous-Derived Astaxanthin Regulates Lipid Metabolism and Gut Microbiota in Obese Mice Induced by A High-Fat Diet

Anthocyanin Improving Metabolic Disorders in Obese Mice from Aornia Melanocarpa

Dietary Supplementation of Black Rice Anthocyanin Extract Regulates Cholesterol Metabolism and Improves Gut Microbiota Dysbiosis in C57BL/6J Mice Fed a High-Fat and Cholesterol Diet

Dietary açai modulates ROS production by neutrophils and gene expression of liver antioxidant enzymes in rats